ARS Pharmaceuticals, Inc. (SPRY) stock
SPRYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.65+0.06 (+1.67%)
Close on Nov 17, 2026Market cap $362.98MP/E –Yield –
ARS Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
ARS Pharmaceuticals's price to book ratio was 31.4× on Nov 11, 2026, against 6.4× a year earlier. Over the last 5 years it ranged from 0.5× to 47.7×, with a median of 4.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 31.4× | +23.6 |
| 2025 | Dec 31, 2025 | 7.8× | +2.7 |
| 2024 | Dec 31, 2024 | 5.1× | +2.9 |
| 2023 | Dec 29, 2023 | 2.2× | +1.7 |
| 2022 | Jan 31, 2022 | 0.5× | −0.2 |
| 2021 | Dec 31, 2021 | 0.7× | – |
See a number that looks wrong?